AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2025
Oct 8, 2025
35599_dirs_2025-10-08_51ea0499-593a-4d81-ae06-5a59d0b71d16.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2025-10-08
Reporting Person: Raykov Rosty (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-10-08 | Common shares | M | 4609 | $2.45 | Acquired | 87110 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-10-08 | Stock Options | $2.45 | M | 4609 | Disposed | 2026-07-05 | options (4609) | Direct |
Footnotes
F1: Shares acquired through the exercise of an option contract with strike price of $2.45 and an expiration date of July 5, 2026.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20